Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors.
- Author:
Fei LI
1
;
Zhiyong ZHONG
;
Rui LI
;
Heyu HUANG
;
Lijun WANG
;
Donghan ZHENG
;
Daorong ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adenocarcinoma; genetics; metabolism; pathology; Basic Helix-Loop-Helix Transcription Factors; genetics; metabolism; Carcinoma, Large Cell; genetics; metabolism; pathology; Carcinoma, Neuroendocrine; genetics; metabolism; pathology; Carcinoma, Squamous Cell; genetics; metabolism; pathology; Gene Expression Regulation, Neoplastic; genetics; physiology; Humans; Immunohistochemistry; Lung Neoplasms; genetics; metabolism; pathology; Neuroendocrine Tumors; genetics; metabolism; pathology; Reverse Transcriptase Polymerase Chain Reaction; Small Cell Lung Carcinoma; genetics; metabolism; pathology
- From: Chinese Journal of Lung Cancer 2010;13(4):317-321
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND AND OBJECTIVEHuman achaete-scute homolog 1 (hASH1) gene plays a critical role in development of the central nervous system, automatic nervous system, adrenal medullary chromaffin cells, thyroid C cells and pulmonary neuroendocrine cells. The aim of this study is to determine hASH1 gene expression in the normal lung tissue and various types of lung tumors, to analyze whether its expression correlated with pulmonary neuroendocrine markers, and to explore the possibility of hASH1 as clinical pathological markers in the neuroendocrine tumors compared with previous neuroendocrine tumor markers.
METHODShASH1, Chromogranin A, Synaptophysin and CD56 expression were examined in lung tumor specimens (lung inflammatory pseudotumor, squamous cell carcinoma, adenocarcinomas, large cell carcinoma, typical carcinoids, atypical carcinoids, large cell neuroendocrine carcinomas and small cell lung carcinoma and corresponding normal lung specimens) using immunohistochemistry (S-P method). Western blot and reverse transcription polymerase chain reaction (RT-PCR) assay were applied to detect the expressions of hASH1 protein and mRNA in lung cancer tissues.
RESULTShASH1 expression was positive in 2/16 (12.5%) typical carcinoids, 15/20 (75%) atypical carcinoids, 6/10 (60%) large cell neuroendocrine carcinomas and 31/40 (77.5%) small cell lung carcinoma, respectively, but not in any normal lung tissue (0/10), lung inflammatory pseudotumor (0/49), squamous cell carcinoma (0/30), adenocarcinomas (0/30) or large cell carcinoma (0/20). There was a significant difference in hASH1 expression between typical carcinoids and atypical carcinoids (P < 0.01), but not in large cell neuroendocrine carcinomas and small cell lung carcinoma (P > 0.05). hASH1 expression highly closely correlated with Chromogranin A, Synaptophysin and CD56 expression (P < 0.05).
CONCLUSIONhASH1 is a new kind of highly specific markers of pulmonary neuroendocrine tumours, and may be applied to clinical pathology diagnosis of the pulmonary neuroendocrine tumors.